Individuals affected by CACNA1B variants presented with epileptic encephalopathy, severe neurodevelopmental delay, hyperkinetic movement disorder (myoclonus-dystonia syndrome), postnatal microcephaly, and hypotony [56, 57]. This evidence concerns the gene CACNA1B and Epileptic encephalopathy.